Patent details

Herbas

VPB

Print

EN | LT

LT - USE OF APLIDINE FOR THE TREATMENT OF PANCREATIC CANCER

EN - USE OF APLIDINE FOR THE TREATMENT OF PANCREATIC CANCER

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 38/15
		A61P 35/00

European patent
(11)	Number of the document	1435991
(13)	Kind of document	T
(96)	European patent application number	02770106.9
	Date of filing the European patent application	2002-10-21
(97)	Date of publication of the European application	2004-07-14
(45)	Date of publication and mention of the grant of the patent	2008-10-15
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/GB2002/004816
	Date	2002-10-21

PCT application publication
(87)	Number	WO 2003/033013
	Date	2003-04-24

Priority applications
(30)	Number	Date	Country code
	348412 P	2001-10-19	US
	0208624	2002-04-15	GB

Inventors
(72)	MANGUES, R., I. Ric. del H. - Santa Cruz/Pablo, ES HENRIQUEZ, R., NeuroPharma S.A.U., ES JIMENO, J.,Pharma Mar,S.A.U.,Polig.Industr.La Mina, ES

Grantee
(73)	PHARMA MAR, S.A., Calle de la Calera 3, Poligono Industrial de Tres Cantos, 28760 Tres Cantos, Madrid, ES

Title
(54)	USE OF APLIDINE FOR THE TREATMENT OF PANCREATIC CANCER
	USE OF APLIDINE FOR THE TREATMENT OF PANCREATIC CANCER